Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2022 Jul 22;10(7):e6030. doi: 10.1002/ccr3.6030

Allergic bronchopulmonary mycosis characterized by chest pain and high‐attenuation mucus on computed tomography

Risa Hirata 1, Masaki Tago 1,, Seijiro Makio 1,2, Toru Oishi 1,2, Yoshimasa Oda 2
PMCID: PMC9307877  PMID: 35898754

Abstract

A 45‐year‐old woman developed chest pain on the previous day. High‐attenuation mucus in the bronchus was found on the CT examination on admission, which led to a diagnosis of allergic bronchopulmonary mycosis. CT should be checked carefully for high‐attenuation mucus because this finding is highly specific for allergic bronchopulmonary mycosis.

Keywords: allergic bronchopulmonary aspergillosis, allergic bronchopulmonary mycosis, chest pain, high‐attenuation mucus

Short abstract

High‐attenuation mucus on CT examination leads to a diagnosis of allergic bronchopulmonary mycosis. Therefore, CT should be checked carefully for high‐attenuation mucus because this finding is highly specific for allergic bronchopulmonary mycosis.

1. CASE

A 45‐year‐old woman with a history of asthma visited our hospital with chest pain from the previous day. Physical examination revealed tachypnea, percutaneous oxygen saturation of 98% on room air, and diminished breath sounds in the left lower lung field. A chest radiograph and plain chest computed tomography (CT) revealed infiltrating shadows in the left upper and right middle lobe (Figures 1 and 2, arrowheads). Treatment with intravenous ampicillin‐sulbactam for 1 week was unsuccessful. Laboratory tests subsequently became available and showed the following: eosinophils 1,343 /μL, immunoglobulin E 1,010 IU/mL, and β‐d‐glucan 194 pg/mL. Retrospective review of CT scans obtained on admission revealed high‐attenuation mucus (HAM) in the left upper and right middle lobe bronchi (Figure 2B, arrow; Figure 3A–C, arrowheads). Therefore, the patient met the criteria for a diagnosis of allergic bronchopulmonary mycosis (ABPM). 1 She was started on prednisolone 40 mg/day and her symptoms and laboratory parameters improved.

FIGURE 1.

FIGURE 1

Chest radiograph obtained on admission. Infiltrative shadows (arrowheads) can be seen in the left lower lung field

FIGURE 2.

FIGURE 2

Simple chest computed tomography scan obtained on admission (lung window). Infiltrative shadows are present in the left upper lobe and right middle lobe ((A–D) arrowheads). A mucus plug can be seen in the left upper lobe bronchus ((B) arrow)

FIGURE 3.

FIGURE 3

Simple chest computed tomography scans obtained on admission (mediastinal window). High‐attenuation mucus is visible in the left upper lobe bronchus and the right middle lobe bronchus ((A–C) arrowheads)

Although we did not recognize HAM on CT initially, its presence has a sensitivity of 39.7% and a specificity of 100% for ABPM. 2 For early diagnosis and treatment of ABPM, it is important to check for HAM on CT and be aware of its high specificity for ABPM.

AUTHOR CONTRIBUTIONS

RH was involved in the literature search, study conception, and drafting of the manuscript. MT was involved in the literature search, study conception, and drafting and revision of the manuscript. SM was involved in the literature search and study conception. TO was involved in the literature search and clinical care of the patient. YO was involved in the literature search, clinical care of the patient, and revision of the manuscript.

CONFLICT OF INTEREST

The authors stated that they have no conflict of interest.

ETHICAL APPROVAL

This manuscript conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Brazil 2013).

CONSENT

Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.

ACKNOWLEDGEMENT

We thank Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Hirata R, Tago M, Makio S, Oishi T, Oda Y. Allergic bronchopulmonary mycosis characterized by chest pain and high‐attenuation mucus on computed tomography. Clin Case Rep. 2022;10:e06030. doi: 10.1002/ccr3.6030

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1. Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147(4):1261‐1268.e5. doi: 10.1016/j.jaci.2020.08.029 [DOI] [PubMed] [Google Scholar]
  • 2. Agarwal R, Maskey D, Aggarwal AN, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One. 2013;8(4):e61105. doi: 10.1371/journal.pone.0061105 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES